Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Squibb Begins Tender Offer to Acquire Inhibitex, Inc.
Yahoo
Friday, January 13, 2012 - 9:27am
tags:
Inhibitex, tender offer, M&A, Bristol-Myers Squibb
Swiss drug maker Novartis to cut almost 2,000 US jobs this year on patent expiry, failed trial
Yahoo/AP
Friday, January 13, 2012 - 9:26am
tags:
Novartis, layoffs
11 Biotech Bets For 2012
Seeking Alpha
Thursday, January 12, 2012 - 10:16pm
tags:
Zalicus, Teva Pharmaceuticals, Spectrum, Astex, Aeterna Zentaris, Cel-Sci, Dendreon, Keryx, NPS Pharmaceuticals, Pharmacyclics, Questcor
Investors Waiting For Aastrom To Raise Cash
Seeking Alpha
Thursday, January 12, 2012 - 10:13pm
tags:
Aastrom Biosciences, critical limb ischemia, ixmyelocel-T
Sales of Lipitor Are Leveling Off
NY Times, NY
Thursday, January 12, 2012 - 10:09pm
tags:
Lipitor, Pfizer, generics
Nestle Said to Vie With Danone in Bids to Acquire Pfizer’s Baby-Food Unit
Bloomberg
Thursday, January 12, 2012 - 10:08pm
tags:
Nestle, Danone SA, infant nutrition, Pfizer
Inhibitex Shareholders Sue Over Bristol’s $2.5 Billion Offer
Bloomberg
Thursday, January 12, 2012 - 10:07pm
tags:
shareholders, M&A, Inhibitex, Bristol-Myers Squibb
J&J Whistle-Blower Recounts Firing After Finding Payments
Bloomberg
Thursday, January 12, 2012 - 10:06pm
tags:
JNJ, Risperdal, whistleblower lawsuits
To Bolster Pipeline, Glaxo Exec Scouts Prospects
WSJ Online
Thursday, January 12, 2012 - 10:05pm
tags:
GSK
Europe’s Drugmakers May Boost Acquisitions After Buyback Focus
Bloomberg Businessweek
Thursday, January 12, 2012 - 2:11pm
tags:
Europe, M&A, patents, GSK, Roche, AstraZeneca, Novartis
Why The Medicines Co. May Be About to Take Off
Motley Fool
Thursday, January 12, 2012 - 2:04pm
tags:
Medicines Company
N.J. Botox Tax Repeal Awaits Christie Decision
Forbes
Thursday, January 12, 2012 - 2:04pm
tags:
New Jersey, Botox, Allergan
Is 'Worthless' Really A Fair Assessment Of Targacept?
Seeking Alpha
Thursday, January 12, 2012 - 2:02pm
tags:
Targacept, Forest Labs, AstraZeneca, Pfizer, JNJ
Lilly’s Zyprexa $4.5 Million Pact With Health Providers Wins Approval
Bloomberg
Thursday, January 12, 2012 - 1:57pm
tags:
Zyprexa, third party payors, schizophrenia, Lilly
United Therapeutics Gets Upgrade on Revenue Growth
TheStreet.com
Thursday, January 12, 2012 - 11:01am
tags:
United Therapeutics
30% Safe Upside For Merck, Amgen
Seeking Alpha
Thursday, January 12, 2012 - 10:54am
tags:
Amgen, Merck
Abbott says no bid on rival Pfizer's baby, infant nutrition business
Crain's Chicago Business, IL
Thursday, January 12, 2012 - 9:17am
tags:
Abbott Laboratories, infant nutrition, Pfizer, M&A
Statins Linked to Small Diabetes Risk
ABC News/AP
Thursday, January 12, 2012 - 9:16am
tags:
statins, diabetes
Interferon's Role In Flu Control Shouldn't Be Underestimated
Seeking Alpha
Thursday, January 12, 2012 - 9:11am
tags:
interferon, Flu, Hemispherx, Roche, Novavax, Sinovac
European Scandal Could Help Cytori Therapeutics
Seeking Alpha
Thursday, January 12, 2012 - 9:10am
tags:
Europe, Cytori

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.